Adhesion Molecule Targeted Therapy for Non-Infectious Uveitis.

Cell Adhesion Molecules Humans Inflammation Molecular Targeted Therapy Uveitis / metabolism
adhesion molecule experimental autoimmune uveitis integrin intercellular cell adhesion molecule-1 (ICAM-1) lymphocyte function-associated antigen-1 (LFA-1) non-infectious uveitis selectin uveitis vascular cell adhesion protein 1 (VCAM-1) very late antigen-4 (VLA-4)

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
03 Jan 2022
Historique:
received: 03 11 2021
revised: 08 12 2021
accepted: 11 12 2021
entrez: 11 1 2022
pubmed: 12 1 2022
medline: 15 2 2022
Statut: epublish

Résumé

Non-infectious uveitis (NIU) is an inflammatory eye disease initiated via CD4

Identifiants

DOI: 10.3390/ijms23010503 PMID: 35008929 PMC: PMC8745221
pubmed: 35008929
pii: ijms23010503
doi: 10.3390/ijms23010503
pmc: PMC8745221
pii:
doi:

Substances chimiques

Cell Adhesion Molecules 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Linkou Chang Gung Memorial Hospital
ID : CMRPG5D0041

Références

Immunol Res. 2009 Dec;45(2-3):195-208
pubmed: 19184539
Genome Biol. 2007;8(5):215
pubmed: 17543136
Br J Ophthalmol. 1999 Jul;83(7):847-51
pubmed: 10381673
J Immunol. 1992 Apr 1;148(7):1985-92
pubmed: 1372018
Curr Eye Res. 1993 Sep;12(9):827-31
pubmed: 7903235
Curr Eye Res. 2000 Nov;21(5):906-12
pubmed: 11262613
Ophthalmic Surg Lasers Imaging Retina. 2021 Jun;52(6):327-335
pubmed: 34185587
Curr Eye Res. 1992;11 Suppl:161-6
pubmed: 1358555
Invest Ophthalmol Vis Sci. 2002 May;43(5):1499-508
pubmed: 11980866
Invest Ophthalmol Vis Sci. 2003 Jan;44(1):226-34
pubmed: 12506079
Curr Eye Res. 2000 Apr;20(4):287-92
pubmed: 10806443
Invest Ophthalmol Vis Sci. 2005 Jun;46(6):2056-63
pubmed: 15914623
Front Immunol. 2019 May 22;10:1078
pubmed: 31231358
Biochem Pharmacol. 2008 Sep 15;76(6):751-62
pubmed: 18680729
Allerg Immunol (Paris). 1996 Nov;28(9):302-6
pubmed: 8986245
Arch Ophthalmol. 1992 May;110(5):662-6
pubmed: 1374609
J Immunol. 2004 Mar 1;172(5):3215-24
pubmed: 14978129
Semin Ophthalmol. 2018;33(5):634-642
pubmed: 29087767
Clin Exp Immunol. 2007 Jan;147(1):71-80
pubmed: 17177965
J Clin Invest. 2010 Sep;120(9):3073-83
pubmed: 20811163
Clin Immunol Immunopathol. 1993 May;67(2):143-50
pubmed: 8100190
Ther Adv Ophthalmol. 2019 Aug 22;11:2515841419870366
pubmed: 31489402
Microvasc Res. 1998 May;55(3):230-40
pubmed: 9657923
Invest Ophthalmol Vis Sci. 1997 Nov;38(12):2608-18
pubmed: 9375580
Eur J Immunol. 1993 Sep;23(9):2181-8
pubmed: 7690324
Indian J Ophthalmol. 2018 Oct;66(10):1441-1445
pubmed: 30249830
Immunology. 1996 Jul;88(3):456-62
pubmed: 8774365
J Ocul Pharmacol Ther. 2018 Sep;34(7):543-549
pubmed: 29958030
Front Cell Dev Biol. 2021 Feb 03;9:612830
pubmed: 33614645
Invest Ophthalmol Vis Sci. 2011 Sep 01;52(9):6919-24
pubmed: 21498606
Clin Exp Rheumatol. 1999 Mar-Apr;17(2):179-84
pubmed: 10342043
J Neurol Neurosurg Psychiatry. 2020 Jun;91(6):660-668
pubmed: 32234967
J Ophthalmol. 2015;2015:138070
pubmed: 25802751
Exp Mol Med. 2013 Oct 18;45:e49
pubmed: 24136464
Eur J Immunol. 2011 Mar;41(3):813-21
pubmed: 21341265
Immunology. 1995 Nov;86(3):408-15
pubmed: 8550078
Ann Rheum Dis. 2000 Jan;59(1):61-3
pubmed: 10627429
Clin Ophthalmol. 2019 Nov 22;13:2285-2292
pubmed: 31819353
J Clin Invest. 1998 Dec 15;102(12):2096-105
pubmed: 9854045
Ocul Immunol Inflamm. 1998 Jun;6(2):81-92
pubmed: 9689638
Clin Immunol. 2014 Jul;153(1):136-44
pubmed: 24787891
Ryumachi. 1994 Jun;34(3):608-15
pubmed: 7519790
J Ophthalmic Inflamm Infect. 2013 Nov 06;3(1):64
pubmed: 24195808
Front Immunol. 2021 Apr 30;12:623725
pubmed: 33995347
Invest Ophthalmol Vis Sci. 2007 Jun;48(6):2667-75
pubmed: 17525198
Curr Eye Res. 1993 Oct;12(10):923-34
pubmed: 8293668
J Neurovirol. 2015 Dec;21(6):614-22
pubmed: 25740538
Ophthalmic Epidemiol. 2021 Dec;28(6):461-468
pubmed: 33557663
Invest Ophthalmol Vis Sci. 1998 Aug;39(9):1620-30
pubmed: 9699551
Arch Ophthalmol. 1992 Jan;110(1):121-5
pubmed: 1731706
Klin Monbl Augenheilkd. 2018 Apr;235(4):476-477
pubmed: 29452449
Cell. 2019 Apr 18;177(3):499-501
pubmed: 30952447
Clin Exp Immunol. 1994 Jan;95(1):60-5
pubmed: 7507016
J Neuroinflammation. 2021 Feb 18;18(1):49
pubmed: 33602234
Clin Immunol Immunopathol. 1997 Apr;83(1):45-52
pubmed: 9073535
Core Evid. 2020 Apr 01;15:7-20
pubmed: 32280316
Am J Ophthalmol. 2018 May;189:77-85
pubmed: 29505775
Exp Eye Res. 2015 Aug;137:94-102
pubmed: 26093277
Exp Eye Res. 2019 Mar;180:43-52
pubmed: 30472075
J Leukoc Biol. 1998 Oct;64(4):434-40
pubmed: 9766623
Invest Ophthalmol Vis Sci. 1995 Oct;36(11):2262-9
pubmed: 7558720
Invest Ophthalmol Vis Sci. 2013 Oct 23;54(10):6917-25
pubmed: 24022011
Br J Ophthalmol. 1998 Apr;82(4):432-7
pubmed: 9640196
Dig Dis Sci. 2018 Apr;63(4):825-833
pubmed: 29484571
Invest Ophthalmol Vis Sci. 1994 Apr;35(5):2626-31
pubmed: 7909311

Auteurs

Yi-Hsing Chen (YH)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
Department of Ophthalmology, Chang Gung Memorial Hospital, Taoyuan 333, Taiwan.
College of Medicine, Chang Gung University, Taoyuan 333, Taiwan.

Sue Lightman (S)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.

Malihe Eskandarpour (M)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.

Virginia L Calder (VL)

UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UK.
NIHR Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust, London EC1V 2PD, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Facteurs biologiques › Antigènes › Antigènes de surface › Molécules d'adhérence cellulaire › Adhesion Molecule Targeted Therapy for...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Adhesion Molecule Targeted Therapy for...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Inflammation › Adhesion Molecule Targeted Therapy for...
questionsmedicales.fr › Thérapeutique › Traitement médicamenteux › Thérapie moléculaire ciblée › Adhesion Molecule Targeted Therapy for...
questionsmedicales.fr › Maladies de l'oeil › Maladies de l'uvée › Uvéite › Adhesion Molecule Targeted Therapy for...